title: Myoblast transplantation for heart failure: where are we heading?
authors.forename: Ottavio
authors.initials: O
authors.lastname: Alfieri
authors.forename: Ugolino
authors.initials: U
authors.lastname: Livi
authors.forename: Luigi
authors.initials: L
authors.lastname: Martinelli
authors.forename: Giorgio
authors.initials: G
authors.lastname: Arpesella
authors.forename: Carlo
authors.initials: C
authors.lastname: Valfrè
authors.forename: Elisabetta
authors.initials: E
authors.lastname: Lapenna
authors.forename: Michel
authors.initials: M
authors.lastname: Desnos
authors.forename: Albert A
authors.initials: AA
authors.lastname: Hagège
authors.forename: Philippe
authors.initials: P
authors.lastname: Menasché
mesh_terms: D000818:Animals; D017690:Cell Transplantation / Q000592:standards* / Q000639:trends; D002986:Clinical Trials as Topic; D004195:Disease Models, Animal; D005544:Forecasting; D006084:Graft Rejection; D006085:Graft Survival; D006333:Heart Failure / Q000175:diagnosis* / Q000401:mortality / Q000628:therapy*; D006801:Humans; D032446:Myoblasts / Q000637:transplantation*; D011379:Prognosis; D018570:Risk Assessment; D012720:Severity of Illness Index; D015996:Survival Rate